HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yi-Hsien Hsieh Selected Research

abietic acid

1/2017Erratum: "The Inhibitory Effect of Abietic Acid on Melanoma Cancer Metastasis and Invasiveness In Vitro and In Vivo".
1/2015The Inhibitory Effect of Abietic Acid on Melanoma Cancer Metastasis and Invasiveness In Vitro and In Vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yi-Hsien Hsieh Research Topics

Disease

90Neoplasms (Cancer)
06/2022 - 02/2007
40Neoplasm Metastasis (Metastasis)
06/2022 - 05/2007
33Hepatocellular Carcinoma (Hepatoma)
01/2022 - 08/2006
17Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2022 - 02/2012
11Osteosarcoma (Osteogenic Sarcoma)
06/2022 - 11/2016
11Mouth Neoplasms (Oral Cancer)
01/2022 - 09/2010
7Fibrosis (Cirrhosis)
04/2022 - 12/2005
7Breast Neoplasms (Breast Cancer)
05/2021 - 09/2011
6Mitochondrial Diseases (Mitochondrial Disease)
11/2021 - 01/2017
6Glioma (Gliomas)
12/2018 - 04/2004
5Kidney Neoplasms (Kidney Cancer)
06/2022 - 01/2018
5Squamous Cell Carcinoma of Head and Neck
01/2022 - 05/2012
5Glioblastoma (Glioblastoma Multiforme)
10/2021 - 01/2015
5Inflammation (Inflammations)
09/2021 - 10/2011
5Renal Cell Carcinoma (Grawitz Tumor)
04/2020 - 09/2015
5Carcinogenesis
01/2018 - 05/2007
5Lung Neoplasms (Lung Cancer)
01/2018 - 12/2014
4Chronic Renal Insufficiency
04/2022 - 09/2020
4Prostatic Neoplasms (Prostate Cancer)
11/2021 - 09/2013
3Carcinoma (Carcinomatosis)
05/2022 - 01/2017
3Hypoxia (Hypoxemia)
03/2021 - 05/2012
3Hypertension (High Blood Pressure)
01/2017 - 01/2005
3Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases)
10/2011 - 06/2009
3Cardiomegaly (Heart Hypertrophy)
12/2005 - 01/2005
2Ureteral Obstruction
11/2021 - 01/2021
2Wounds and Injuries (Trauma)
04/2020 - 12/2017
2Uveal melanoma
05/2018 - 01/2014

Drug/Important Bio-Agent (IBA)

30Proteins (Proteins, Gene)FDA Link
06/2022 - 01/2005
10Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
09/2021 - 12/2010
9Matrix Metalloproteinases (MMPs)IBA
01/2019 - 08/2011
8Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2010
8FlavonoidsIBA
03/2019 - 02/2012
7Messenger RNA (mRNA)IBA
04/2022 - 04/2004
7Plasminogen Activators (Plasminogen Activator)IBA
09/2021 - 12/2010
6Caspase 3 (Caspase-3)IBA
06/2022 - 02/2012
6MelatoninIBA
04/2022 - 11/2016
6mangostinIBA
11/2020 - 12/2013
6licochalcone AIBA
11/2019 - 01/2014
6fisetinIBA
01/2019 - 02/2012
6Peptide Hydrolases (Proteases)FDA Link
12/2018 - 08/2011
5norcantharidinIBA
11/2021 - 01/2012
5AntioxidantsIBA
01/2021 - 10/2013
5CaspasesIBA
11/2019 - 12/2013
5Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2019 - 08/2012
5Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2019 - 12/2005
4MicroRNAs (MicroRNA)IBA
04/2022 - 12/2015
4Sorafenib (BAY 43-9006)FDA Link
04/2022 - 12/2014
4Lipocalin-2IBA
06/2021 - 12/2012
4p38 Mitogen-Activated Protein KinasesIBA
03/2018 - 05/2007
4Matrix Metalloproteinase 9 (Gelatinase B)IBA
10/2017 - 01/2015
4PTX3 proteinIBA
01/2016 - 10/2011
4Protein Kinase C-alphaIBA
01/2015 - 02/2007
3CurcuminIBA
06/2022 - 05/2021
3Small Interfering RNA (siRNA)IBA
01/2022 - 10/2013
3SaponinsIBA
01/2022 - 01/2018
3CollagenIBA
11/2021 - 01/2020
3Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
09/2021 - 04/2018
3Anticarcinogenic AgentsIBA
05/2021 - 01/2017
3praeruptorin AIBA
04/2021 - 12/2017
3anomalinIBA
04/2020 - 01/2019
3cathepsin SIBA
01/2020 - 10/2017
3Retinal Pigments (Pigments, Visual)IBA
01/2020 - 05/2018
3Caspase 8 (Caspase-8)IBA
05/2016 - 02/2012
3Protein Kinases (Protein Kinase)IBA
01/2015 - 05/2007
3Chloride-Bicarbonate AntiportersIBA
07/2009 - 08/2006
2(3,5- bis((4- fluorophenyl)methylidene)- 1- ((1- hydroxy- 2,2,5,5- tetramethyl- 2,5- dihydro- 1H- pyrrol- 3- yl)methyl)piperidin- 4- one)IBA
06/2022 - 01/2022
2U 0126 (UO 126)IBA
05/2022 - 01/2019
2protodioscinIBA
01/2022 - 01/2018
2Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 05/2016
2ChemokinesIBA
11/2021 - 10/2018
2CytokinesIBA
11/2021 - 06/2021
2VimentinIBA
11/2021 - 01/2020
2Reactive Oxygen Species (Oxygen Radicals)IBA
11/2021 - 07/2017
2Paclitaxel (Taxol)FDA LinkGeneric
11/2021 - 01/2015
2corosolic acidIBA
10/2021 - 08/2021
2Chemokine ReceptorsIBA
05/2021 - 09/2010
2FITC-annexin A5IBA
05/2021 - 09/2019
2timosaponin AIIIIBA
03/2021 - 01/2019
2IntegrinsIBA
03/2021 - 11/2020
2Carbonic Anhydrase IXIBA
03/2021 - 10/2017
2Transcription Factors (Transcription Factor)IBA
01/2021 - 12/2015
2Epidermal Growth Factor (EGF)IBA
01/2020 - 01/2015
2Cadherins (E-Cadherin)IBA
01/2020 - 09/2011
2Metalloproteases (Metalloproteinases)IBA
01/2020 - 01/2016
2Apoptosis Regulatory ProteinsIBA
12/2019 - 07/2012
2Annexin A5IBA
11/2019 - 01/2018
2JNK Mitogen-Activated Protein KinasesIBA
10/2018 - 11/2016
2Caspase 9IBA
09/2018 - 07/2017
2nimbolideIBA
09/2018 - 09/2015
2Cantharidin (Cantharides)IBA
03/2018 - 10/2017
2Cyclin D1IBA
12/2017 - 02/2017
2xanthoneIBA
11/2017 - 12/2013
2hispolonIBA
10/2017 - 10/2013
2Cytochromes c (Cytochrome c)IBA
07/2017 - 12/2013
2abietic acidIBA
01/2017 - 01/2015
2Pharmaceutical PreparationsIBA
01/2017 - 01/2012
2NF-kappa B (NF-kB)IBA
01/2017 - 01/2012

Therapy/Procedure

8Therapeutics
10/2021 - 02/2007
6Drug Therapy (Chemotherapy)
06/2022 - 05/2016
3Chemoprevention
10/2015 - 01/2014